161 related articles for article (PubMed ID: 37479748)
1. Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice.
Fu Q; Frick JM; O'Neil MF; Eller OC; Morris EM; Thyfault JP; Christianson JA; Lane RH
Pediatr Res; 2023 Dec; 94(6):1942-1950. PubMed ID: 37479748
[TBL] [Abstract][Full Text] [Related]
2. Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring.
Fu Q; North PE; Ke X; Huang YW; Fritz KA; Majnik AV; Lane RH
J Nutr; 2021 Oct; 151(10):3102-3112. PubMed ID: 34486661
[TBL] [Abstract][Full Text] [Related]
3. Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD).
Castro RQ; Soto Rodriguez I; Deschamps Lago RA; Pagola PG; Rodriguez Antolin J; Peres Quintal A; Rivera JR; Aguilera AA
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):99-106. PubMed ID: 29765172
[TBL] [Abstract][Full Text] [Related]
4. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
5. High-fat/high-sucrose diet worsens metabolic outcomes and widespread hypersensitivity following early-life stress exposure in female mice.
Frick JM; Eller OC; Foright RM; Levasseur BM; Yang X; Wang R; Winter MK; O'Neil MF; Morris EM; Thyfault JP; Christianson JA
Am J Physiol Regul Integr Comp Physiol; 2023 Mar; 324(3):R353-R367. PubMed ID: 36693166
[TBL] [Abstract][Full Text] [Related]
6. Early life stress reduces voluntary exercise and its prevention of diet-induced obesity and metabolic dysfunction in mice.
Eller OC; Morris EM; Thyfault JP; Christianson JA
Physiol Behav; 2020 Sep; 223():113000. PubMed ID: 32512033
[TBL] [Abstract][Full Text] [Related]
7. Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.
Lee J; Song JH; Park JH; Chung MY; Lee SH; Jeon SB; Park SH; Hwang JT; Choi HK
Exp Mol Med; 2023 Jan; 55(1):143-157. PubMed ID: 36609599
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
[TBL] [Abstract][Full Text] [Related]
9. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36.
Zhang H; Li Y; Zhang C; Huang K; Zhao J; Le S; Jiang L; Liu H; Yang P; Xiao X; Yu J; Wu J; Ye P; Xia J
Cell Death Dis; 2022 Apr; 13(4):359. PubMed ID: 35436984
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.
Tryndyak VP; Willett RA; Avigan MI; Sanyal AJ; Beland FA; Rusyn I; Pogribny IP
Epigenetics; 2022 Nov; 17(11):1462-1476. PubMed ID: 35324388
[TBL] [Abstract][Full Text] [Related]
11. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada P; González-Rodríguez Á; García-Monzón C; Valverde ÁM
Cell Death Dis; 2020 Sep; 11(9):802. PubMed ID: 32978374
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
13. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
Zhou SS; Zhang YL; Chang YS
Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
[TBL] [Abstract][Full Text] [Related]
14. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
Zheng E; Chen Q; Xiao A; Luo X; Lu Q; Tian C; Liu H; Zhao J; Wei L; Yang P; Chen Y
Biochem Biophys Res Commun; 2024 May; 707():149781. PubMed ID: 38492244
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease.
Sheedfar F; Sung MM; Aparicio-Vergara M; Kloosterhuis NJ; Miquilena-Colina ME; Vargas-Castrillón J; Febbraio M; Jacobs RL; de Bruin A; Vinciguerra M; García-Monzón C; Hofker MH; Dyck JR; Koonen DP
Aging (Albany NY); 2014 Apr; 6(4):281-95. PubMed ID: 24751397
[TBL] [Abstract][Full Text] [Related]
16. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
17. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
[TBL] [Abstract][Full Text] [Related]
19. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease.
Qiu Y; Liu S; Chen HT; Yu CH; Teng XD; Yao HT; Xu GQ
Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):630-6. PubMed ID: 24322749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
